Qnasl Aerosol, Metered
NDC Package 59310-406-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Qnasl (beclomethasone dipropionate) aerosols is a medication used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching, and sneezing. This formulation utilizes a aerosol, metered delivery system. Marketed by Teva Respiratory, Llc, this product is identified by NDC 59310-406 and is authorized under FDA application NDA202813.

Identification & Billing

NDC Package Code
59310-406-06
Package Description
1 INHALER in 1 CARTON / 60 AEROSOL, METERED in 1 INHALER
Product Code
11-Digit Billing Format
59310040606
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
RxNorm Crosswalk
  • RxCUI: 1797900 - beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Nasal Spray
  • RxCUI: 1797900 - beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Nasal Spray
  • RxCUI: 1797902 - Qnasl 40 MCG/ACTUAT Metered Dose Nasal Spray
  • RxCUI: 1797902 - beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Nasal Spray [Qnasl]
  • RxCUI: 1797902 - Qnasl 0.04 MG/ACTUAT Metered Dose Nasal Spray

Clinical Specifications

Proprietary Name
Qnasl
Non-Proprietary Name
Beclomethasone Dipropionate
Substance Name
Beclomethasone Dipropionate
Dosage Form
Aerosol, Metered - A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Usage Information
This medication is used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching, and sneezing. It may also reduce other symptoms of seasonal allergies such as red, itchy, and watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.

Regulatory & Marketing

Labeler Name
Teva Respiratory, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA202813
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-02-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59310-406). Click a package code to view its specific billing and regulatory data.

1 INHALER in 1 CARTON / 60 AEROSOL, METERED in 1 INHALER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59310-406-06 identifies a specific commercial package of 1 inhaler in 1 carton / 60 aerosol, metered in 1 inhaler of Qnasl, a human prescription drug labeled by Teva Respiratory, Llc. This aerosol, metered is formulated for nasal use and contains beclomethasone dipropionate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Respiratory, Llc on January 02, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching, and sneezing. It may also reduce other symptoms of seasonal allergies such as red, itchy, and watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.

How is this Teva Respiratory, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59310040606. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59310-406-06
11-Digit CMS (5-4-2)
59310-0406-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.